Basic information Safety Supplier Related

11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine

Basic information Safety Supplier Related

11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine Basic information

Product Name:
11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
Synonyms:
  • 11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
  • Dopamine serotonin antagonist-1
  • Dechloroclozapine
  • 5H-Dibenzo[b,e][1,4]diazepine, 11-(4-methyl-1-piperazinyl)-
  • 11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepineQ: What is 11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine Q: What is the CAS Number of 11-(4-Methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
  • inhibit,Inhibitor,Muscarinic acetylcholine receptor,hM4Di,Deschloroclozapine,hM3Dq,muscarinic-based,mAChR,DREADDs
  • 11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
  • Deschloroclozapine, 10 mM in DMSO
CAS:
1977-07-7
MF:
C18H20N4
MW:
292.38
Mol File:
1977-07-7.mol
More
Less

11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine Chemical Properties

Boiling point:
457.5±55.0 °C(Predicted)
Density 
1.22±0.1 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Room temperature
solubility 
DMSO : ≥ 83.3 mg/mL (284.90 mM)
pka
7.82±0.20(Predicted)
form 
solid
color 
Yellow
More
Less

11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine Usage And Synthesis

Biological Activity

Deschloroclozapine is a potent, high-affinity, selective, metabolically stable agonist of muscarinic-based DREADDs.

Synthesis

109-01-3

5814-41-5

1977-07-7

General procedure for the synthesis of 11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,E][1,4]diazepin-11-one from N-methylpiperazine and 5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one: 5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one (105 mg , 0.5 mmol) was placed in a 50 mL round bottom flask. N,N-dimethylaniline (36.3 mg, 0.3 mmol) was added sequentially. An appropriate amount of super-dry trichlorophosphorus and a magnetic stirrer were added and the mixture was stirred under reflux conditions for 12 h at 130°C under nitrogen protection. Upon completion of the reaction, the excess phosphorous trichloride was removed by distillation. Subsequently, the reaction was terminated by adding an appropriate amount of N-methylpiperazine and continued stirring for 12 hours. The progress of the reaction was monitored by thin layer chromatography (TLC). The reaction mixture was extracted with ethyl acetate (3 x 70 mL) and washed sequentially with water. The organic layers were combined and dried by adding anhydrous Na2SO4. After filtration, the residue was concentrated. Purification by column chromatography (eluent: dichloromethane/methanol = 25:1) afforded 110 mg of the target product 11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,E][1,4]diazepine in 75% yield.

in vitro

Deschloroclozapine has greater potencies for DREADDs than previous agonists in vitro. Deschloroclozapine is a potent agonist for hM 3 Dq with an EC 50 =0.13 nM. Deschloroclozapine is also a potent agonist for hM 4 Di with an EC 50 =0.081 nM.
Deschloroclozapine is a potent and selective agonist for hM 3 Dq and hM 4 Di, it does not display significant agonistic activity for any of the 318 tests wild-type GPCRs at <10 nM.

b>

target

Ki: 6.3 nM (hM 3 Dq), 4.2 nM (hM 4 Di)

storage

Room temperature

References

[1] Patent: CN108586364, 2018, A. Location in patent: Paragraph 0150; 0151; 0152

11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepineSupplier

Shanghai Hekang Biotechnology Co., Ltd.
Tel
18939837085
Email
youchemicals@gmail.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Email
sales@chem-strong.com
HangZhou YuHao Chemical Technology Co., Ltd.
Tel
0571-82693216
Email
info@yuhaochemical.com
Hangzhou J&H Chemical Co., Ltd.
Tel
0571-87396432
Email
sales@jhechem.com